Morgan Stanley and Citigroup raised price targets on Appian Corporation, with MarketBeat aggregating the consensus data.
1 report, 1 independent
Updated Sep 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley and Citigroup raised price targets on Appian Corporation, with MarketBeat aggregating the consensus data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Appian Corporation
American cloud computing company
Nothing else this week.
-
Morgan Stanley
U.S. investment bank
-
Citigroup
American investment bank and financial services corporation
Related events
- MarketBeat aggregates consensus rating data on Aegon, while Citigroup weighed in and Morgan Stanley downgraded the rating.
- MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
- Morgan Stanley and Citigroup raised price objectives on Amgen shares, with MarketBeat reporting the consensus rating.
- Morgan Stanley provided analyst ratings and price targets for Steel Dynamics, whose stock trades on NASDAQ.
- MarketBeat reported consensus rating for Hikma Pharmaceuticals, while Jefferies increased its target price and gave a buy rating. Berenberg Bank reaffirmed its buy rating, and Citigroup restated a buy rating.